Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Vulnerability in Law and Bioethics.

Fineman MA.

J Health Care Poor Underserved. 2019;30(4S):52-61. doi: 10.1353/hpu.2019.0115.

PMID:
31735718
2.

Impact of Periocular Vibration on Pain Perceived during Intravitreal Injections.

Adam MK, Zheng CX, Fineman MS.

Ophthalmol Retina. 2020 Jan;4(1):113-115. doi: 10.1016/j.oret.2019.07.012. Epub 2019 Jul 25. No abstract available.

PMID:
31523034
3.

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY.

Mein C, Dugel PU, Feiner L, Drenser K, Miller D, Benz M, Meunier E, Moro L, Fineman MS.

Retina. 2019 Jun 21. doi: 10.1097/IAE.0000000000002599. [Epub ahead of print]

PMID:
31259807
4.

Reply.

Weiss SJ, Adam MK, Gao X, Obeid A, Sivalingam A, Fineman MS, Maguire JI, Garg SJ, Haller J, Fischer DH, Hsu J.

Retina. 2019 Aug;39(8):e38-e39. doi: 10.1097/IAE.0000000000002602. No abstract available.

PMID:
31205274
5.

Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes.

Henry RR, Frias JP, Walsh B, Skare S, Hemming J, Burns C, Bicsak TA, Baron A, Fineman M.

PLoS One. 2018 Sep 25;13(9):e0203946. doi: 10.1371/journal.pone.0203946. eCollection 2018.

6.

Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.

Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, Fineman MS, Regillo CD, Maguire JI, Garg SJ, Hsu J.

Ophthalmology. 2019 Mar;126(3):407-413. doi: 10.1016/j.ophtha.2018.07.027. Epub 2018 Aug 2.

PMID:
30077614
7.

ENDOPHTHALMITIS AFTER PARS PLANA VITRECTOMY: Efficacy of Intraoperative Subconjunctival Antibiotics.

Weiss SJ, Adam MK, Gao X, Obeid A, Sivalingam A, Fineman MS, Maguire JI, Garg SJ, Haller J, Fischer DH, Hsu J.

Retina. 2018 Sep;38(9):1848-1855. doi: 10.1097/IAE.0000000000002175.

PMID:
29652690
8.

Metformin-associated lactic acidosis: Moving towards a new paradigm?

Bicsak TA, Walsh B, Fineman M.

Diabetes Obes Metab. 2017 Nov;19(11):1499-1501. doi: 10.1111/dom.12994. Epub 2017 Jun 9. No abstract available.

9.

A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR).

Rahimy E, Pitcher JD 3rd, Hsu J, Adam MK, Shahlaee A, Samara WA, Vander JF, Kaiser RS, Chiang A, Spirn MJ, Fineman MS.

Retina. 2018 May;38(5):962-969. doi: 10.1097/IAE.0000000000001649.

PMID:
28426624
10.

Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy.

Marshall AG, Lee-Kubli C, Azmi S, Zhang M, Ferdousi M, Mixcoatl-Zecuatl T, Petropoulos IN, Ponirakis G, Fineman MS, Fadavi H, Frizzi K, Tavakoli M, Jeziorska M, Jolivalt CG, Boulton AJM, Efron N, Calcutt NA, Malik RA.

Diabetes. 2017 May;66(5):1380-1390. doi: 10.2337/db16-1181. Epub 2017 Feb 15.

11.

Transconjunctival Approach to Scleral Fixation of Posterior Chamber Intraocular Lenses Using Gore-Tex Suture.

Cutler NE, Sridhar J, Khan MA, Gupta OP, Fineman MS.

Retina. 2017 May;37(5):1003-1005. doi: 10.1097/IAE.0000000000001333. No abstract available.

PMID:
27673717
12.

Early Optical Coherence Tomography Findings after Vitreomacular Traction Release.

Rahimy E, Shahlaee A, Ehmann D, Rayess N, Fineman MS, Garg SJ, Ho AC, Hsu J.

Ophthalmology. 2016 Sep;123(9):2046-7. doi: 10.1016/j.ophtha.2016.04.045. Epub 2016 Jun 21. No abstract available.

PMID:
27338012
13.

Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.

DeFronzo RA, Buse JB, Kim T, Burns C, Skare S, Baron A, Fineman M.

Diabetologia. 2016 Aug;59(8):1645-54. doi: 10.1007/s00125-016-3992-6. Epub 2016 May 23.

14.

Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.

Sridhar J, Hsu J, Shahlaee A, Garg SJ, Spirn MJ, Fineman MS, Vander J.

JAMA Ophthalmol. 2016 Apr;134(4):437-43. doi: 10.1001/jamaophthalmol.2016.0045.

PMID:
26914218
15.

The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies.

Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, Baron A, Fineman M.

Diabetes Care. 2016 Feb;39(2):198-205. doi: 10.2337/dc15-0488. Epub 2015 Aug 18.

PMID:
26285584
16.

Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal Detachment.

Setlur VJ, Rayess N, Garg SJ, Hsu J, Luo CK, Regillo CD, Fineman MS, Sivalingam A.

Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug;46(7):702-7. doi: 10.3928/23258160-20150730-03.

PMID:
26247450
17.

INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Storey PP, Ho V, Yeh S, Reddy S, Fang-Yen NH, Pequignot E, Leiby BE, Fineman M, Garg S, Hubbard GB 3rd, Hsu J.

Retina. 2015 Oct;35(10):1992-2000. doi: 10.1097/IAE.0000000000000620.

PMID:
26035396
18.

Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.

Salz DA, Pitcher JD 3rd, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ.

Ophthalmic Surg Lasers Imaging Retina. 2015 Apr;46(4):439-44. doi: 10.3928/23258160-20150422-06.

PMID:
25970864
19.

Speculum versus Bimanual Lid Retraction during Intravitreal Injection.

Rahimy E, Fineman MS, Regillo CD, Spirn MJ, Hsu J, Kaiser RS, Maguire JI, Brown GC, Chiang A.

Ophthalmology. 2015 Aug;122(8):1729-30. doi: 10.1016/j.ophtha.2015.02.001. Epub 2015 Feb 26. No abstract available.

PMID:
25726752
20.

Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes.

Sharma P, Juhn A, Houston SK, Fineman M, Chiang A, Ho A, Regillo C.

Am J Ophthalmol. 2015 May;159(5):861-7.e2. doi: 10.1016/j.ajo.2015.01.034. Epub 2015 Feb 4.

PMID:
25660387
21.

Reply: To PMID 23609121.

Fineman MS, Hsu J, Spirn MJ, Kaiser RS.

Retina. 2014 Apr;34(4):e13. No abstract available.

PMID:
24796006
22.

Bimanual assisted eyelid retraction technique for intravitreal injections.

Fineman MS, Hsu J, Spirn MJ, Kaiser RS.

Retina. 2013 Oct;33(9):1968-70. doi: 10.1097/IAE.0b013e318287da92.

PMID:
23609121
23.

Electroretinographic effects of omega-3 Fatty Acid supplementation on dry age-related macular degeneration.

Gerstenblith AT, Baskin DE, Shah CP, Wolfe JD, Fineman MS, Kaiser RS, Ho AC.

JAMA Ophthalmol. 2013 Mar;131(3):365-9. doi: 10.1001/jamaophthalmol.2013.642.

PMID:
23494041
24.

Serous macular detachment in Waldenström macroglobulinemia: a report of four cases.

Baker PS, Garg SJ, Fineman MS, Chiang A, Alshareef RA, Belmont J, Brown GC.

Am J Ophthalmol. 2013 Mar;155(3):448-55. doi: 10.1016/j.ajo.2012.09.018. Epub 2012 Dec 4.

PMID:
23218691
25.

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.

Buse JB, Nauck M, Forst T, Sheu WH, Shenouda SK, Heilmann CR, Hoogwerf BJ, Gao A, Boardman MK, Fineman M, Porter L, Schernthaner G.

Lancet. 2013 Jan 12;381(9861):117-24. doi: 10.1016/S0140-6736(12)61267-7. Epub 2012 Nov 7.

PMID:
23141817
26.

A novel method of draining intraoperative choroidal detachments during 23-gauge pars plana vitrectomy.

Witkin AJ, Fineman M, Ho AC, Spirn M.

Arch Ophthalmol. 2012 Aug;130(8):1048-50. doi: 10.1001/archophthalmol.2012.1472.

PMID:
22893075
27.

Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment.

Fineman MS, Mace KF, Diamant M, Darsow T, Cirincione BB, Booker Porter TK, Kinninger LA, Trautmann ME.

Diabetes Obes Metab. 2012 Jun;14(6):546-54. doi: 10.1111/j.1463-1326.2012.01561.x. Epub 2012 Feb 10.

PMID:
22236356
28.

GLP-1 based therapies: differential effects on fasting and postprandial glucose.

Fineman MS, Cirincione BB, Maggs D, Diamant M.

Diabetes Obes Metab. 2012 Aug;14(8):675-88. doi: 10.1111/j.1463-1326.2012.01560.x. Epub 2012 Feb 13. Review.

PMID:
22233527
29.

Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response.

Kaiser RS, Gupta OP, Regillo CD, Ho AC, Fineman MS, Vander JF, McNamara JA, Brown GC.

Ophthalmic Surg Lasers Imaging. 2012 Jan-Feb;43(1):13-9. doi: 10.3928/15428877-20111006-01. Epub 2011 Oct 13.

PMID:
21986085
30.

GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.

Jolivalt CG, Fineman M, Deacon CF, Carr RD, Calcutt NA.

Diabetes Obes Metab. 2011 Nov;13(11):990-1000. doi: 10.1111/j.1463-1326.2011.01431.x.

31.

Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing.

Fineman M, Flanagan S, Taylor K, Aisporna M, Shen LZ, Mace KF, Walsh B, Diamant M, Cirincione B, Kothare P, Li WI, MacConell L.

Clin Pharmacokinet. 2011 Jan;50(1):65-74. doi: 10.2165/11585880-000000000-00000.

PMID:
21142268
32.
33.

Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus.

Kothare PA, Linnebjerg H, Isaka Y, Uenaka K, Yamamura A, Yeo KP, de la Peña A, Teng CH, Mace K, Fineman M, Shigeta H, Sakata Y, Irie S.

J Clin Pharmacol. 2008 Dec;48(12):1389-99. doi: 10.1177/0091270008323750.

PMID:
19047364
34.

Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes.

Hsu J, Chen E, Gupta O, Fineman MS, Garg SJ, Regillo CD.

Retina. 2008 Jul-Aug;28(7):937-40. doi: 10.1097/IAE.0b013e31816c6855.

PMID:
18698294
35.

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.

Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M.

Regul Pept. 2008 Nov 29;151(1-3):123-9. doi: 10.1016/j.regpep.2008.07.003. Epub 2008 Jul 16.

PMID:
18675854
36.

Sterile endophthalmitis following intravitreal injection of preservative-free triamcinolone acetonide.

Lam A, Garg SJ, Spirn MJ, Fineman MS, Sivalingam A.

Retin Cases Brief Rep. 2008 Summer;2(3):228-30. doi: 10.1097/ICB.0b013e31811324a0.

PMID:
25390094
37.

Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment.

Shah CP, Ho AC, Regillo CD, Fineman MS, Vander JF, Brown GC.

Retina. 2008 May;28(5):723-8. doi: 10.1097/IAE.0b013e318166976d.

PMID:
18463516
38.

Intravitreal bevacizumab (avastin) in central retinal vein occlusion.

Hsu J, Kaiser RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, Vander JF, Regillo CD, Ho AC.

Retina. 2007 Oct;27(8):1013-9.

PMID:
18040237
39.

Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration.

Ehlers JP, Fintak DR, Gupta OP, Regillo CD, Fineman MS, Ho AC.

Ophthalmic Surg Lasers Imaging. 2007 Sep-Oct;38(5):371-7. doi: 10.3928/15428877-20070901-03.

PMID:
17955841
40.

The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes.

Nelson P, Poon T, Guan X, Schnabel C, Wintle M, Fineman M.

Diabetes Technol Ther. 2007 Aug;9(4):317-26.

PMID:
17705687
41.

Postoperative complications associated with 25-gauge pars plana vitrectomy.

Gupta OP, Weichel ED, Regillo CD, Fineman MS, Kaiser RS, Ho AC, McNamara JA, Vander JE.

Ophthalmic Surg Lasers Imaging. 2007 Jul-Aug;38(4):270-5. doi: 10.3928/15428877-20070701-01.

PMID:
17674916
42.

Pharmacometrics and the transition to model-based development.

Grasela TH, Dement CW, Kolterman OG, Fineman MS, Grasela DM, Honig P, Antal EJ, Bjornsson TD, Loh E.

Clin Pharmacol Ther. 2007 Aug;82(2):137-42. Review.

PMID:
17632539
43.

Pharmacokinetics of an oral drug (acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes.

Kellmeyer TA, Kesty NC, Wang Y, Frias JP, Fineman MS.

J Clin Pharmacol. 2007 Jul;47(7):798-805. Epub 2007 Apr 26.

PMID:
17463219
44.

Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.

Kim D, MacConell L, Zhuang D, Kothare PA, Trautmann M, Fineman M, Taylor K.

Diabetes Care. 2007 Jun;30(6):1487-93. Epub 2007 Mar 12.

PMID:
17353504
45.

Exenatide effects on statin pharmacokinetics and lipid response.

Kothare PA, Linnebjerg H, Skrivanek Z, Reddy S, Mace K, Pena A, Han J, Fineman M, Mitchell M.

Int J Clin Pharmacol Ther. 2007 Feb;45(2):114-20.

PMID:
17323791
46.

Optical coherence tomography findings in acute retinal pigment epitheliitis.

Hsu J, Fineman MS, Kaiser RS.

Am J Ophthalmol. 2007 Jan;143(1):163-5. Epub 2006 Aug 31.

PMID:
17188058
47.

Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment.

Weichel ED, Martidis A, Fineman MS, McNamara JA, Park CH, Vander JF, Ho AC, Brown GC.

Ophthalmology. 2006 Nov;113(11):2033-40.

PMID:
17074564
48.

Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years.

Hurley BR, McNamara JA, Fineman MS, Ho AC, Tasman W, Kaiser RS, Vander JF, Regillo CD, Brown GC.

Retina. 2006 Sep;26(7 Suppl):S16-7.

PMID:
16946671
49.

Photodynamic therapy in young patients.

Lam A, Lee HC, Ho AC, Regillo CD, McNamara JA, Fineman MD.

Ophthalmic Surg Lasers Imaging. 2006 May-Jun;37(3):182-9. doi: 10.3928/15428877-20060501-01.

PMID:
16749253
50.

Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery.

Anderson NG, Fineman MS, Brown GC.

Ophthalmology. 2006 Jan;113(1):42-7. Epub 2005 Dec 19.

PMID:
16360213

Supplemental Content

Loading ...
Support Center